Odim Jonah, Wheat Jeffrey, Laks Hillel, Kobashigawa Jon, Gjertson David, Osugi Andrew, Mukherjee Kaushik, Saleh Saleh
Department of Surgery, Medicine and Pathology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-1741, USA.
J Heart Lung Transplant. 2006 Feb;25(2):162-6. doi: 10.1016/j.healun.2005.07.011.
Renal insufficiency is an established risk factor in patients undergoing cardiovascular surgery. We sought to evaluate the relationship between renal function and outcomes after orthotopic heart transplantation (OHT).
We conducted a retrospective review of 622 adults who underwent 628 consecutive OHTs between 1994 and 2001 at our institution. The recipients were divided into either normal (Group 1) or impaired (Group 2) pre-operative renal function. Impaired renal function was defined as creatinine clearance (CrCl) < 40 ml/min (Cockroft-Gault formula). Meanwhile, patients in Group 1 (normal) were defined by CrCl > or = 40 ml/min. The primary end points of the study were early and late mortality. The secondary end point included post-operative renal failure defined by the requirement of dialysis or renal allograft in the early post-operative period. The Kaplan-Meier method was used to determine actuarial survival.
Early mortality was 7% (38/531) in Group 1 and 17% (16/96) in Group 2 (p = 0.002). Similarly, the death rate per 100 patient-years was 4.8 and 8.1 for the groups, respectively (p = 0.03). Nine percent of patients in Group 1 required post-operative dialysis (49/531), whereas 32% of recipients in Group 2 required this intervention (31/96) (p < 0.001). Early mortality was 41% for patients requiring post-operative dialysis and 3% for those not requiring such intervention (p < 0.001). Early mortality after post-operative dialysis was 41% (20/49) in Group 1 and 42% (13/31) in Group 2 (p = 0.2).
CrCl < 40 ml/min is a useful marker for increased post-operative renal failure and mortality. Recipients who require post-operative dialysis have greatly increased mortality regardless of pre-operative CrCl. Dialysis in patients after heart transplantation carries a prohibitive risk. Dialysis as a bridge to renal transplantation may reduce this high mortality rate.
肾功能不全是接受心血管手术患者的既定风险因素。我们试图评估原位心脏移植(OHT)后肾功能与预后之间的关系。
我们对1994年至2001年间在我们机构连续接受628例OHT的622名成年人进行了回顾性研究。将受者分为术前肾功能正常(第1组)或受损(第2组)。肾功能受损定义为肌酐清除率(CrCl)<40 ml/分钟(Cockcroft-Gault公式)。同时,第1组(正常)患者定义为CrCl≥40 ml/分钟。该研究的主要终点是早期和晚期死亡率。次要终点包括术后肾衰竭,定义为术后早期需要透析或肾移植。采用Kaplan-Meier方法确定精算生存率。
第1组的早期死亡率为7%(38/531),第2组为17%(16/96)(p = 0.002)。同样,两组每100患者年的死亡率分别为4.8和8.1(p = 0.03)。第1组9%的患者术后需要透析(49/531),而第2组32%的受者需要这种干预(31/96)(p < 0.001)。术后需要透析的患者早期死亡率为41%,不需要这种干预的患者为3%(p < 0.001)。第1组术后透析后的早期死亡率为41%(20/49),第2组为42%(13/31)(p = 0.2)。
CrCl<40 ml/分钟是术后肾衰竭和死亡率增加的有用指标。无论术前CrCl如何,术后需要透析的受者死亡率都大大增加。心脏移植后患者的透析风险极高。作为肾移植桥梁的透析可能会降低这种高死亡率。